Cargando…
Patients with eosinophilic gastrointestinal disorders have lower in-hospital mortality rates related to COVID-19
Autores principales: | Qeadan, Fares, Chehade, Mirna, Tingey, Benjamin, Egbert, Jamie, Dellon, Evan S., Peterson, Kathryn A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459462/ https://www.ncbi.nlm.nih.gov/pubmed/34563741 http://dx.doi.org/10.1016/j.jaip.2021.09.022 |
Ejemplares similares
-
The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data
por: Qeadan, Fares, et al.
Publicado: (2022) -
Eosinophilic Esophagitis Patients Are Not at Increased Risk of Severe COVID-19: A Report From a Global Registry
por: Zevit, Noam, et al.
Publicado: (2022) -
In time: Eosinophilic esophagitis: when to suspect it and how to diagnose
it in children and adolescents
por: Chehade, Mirna
Publicado: (2016) -
The association between opioids, environmental, demographic, and socioeconomic indicators and COVID-19 mortality rates in the United States: an ecological study at the county level
por: Qeadan, Fares, et al.
Publicado: (2021) -
Enhancing diversity, equity, inclusion, and accessibility in eosinophilic gastrointestinal disease research: the consortium for eosinophilic gastrointestinal disease researchers’ journey
por: Chehade, Mirna, et al.
Publicado: (2023)